ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/11/2025
Back to search
Official data from USPTO
ABQURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ABQURE
ST13
US500000090779841Class
5, 42, 44
Filing
90779841
Registration
7102820
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/12/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
06/17/2021
Registration date
07/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
06/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
26
Owner location
AMSTERDAM, NL
Examiner
CHADAB, SETH
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
UNIQURE BIOPHARMA B.V.
uniQure IP B.V.
Representatives
Julianne Abelman ABELMAN LAW PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases; Viral systemsgene therapy systemsnucleic acid delivery systemsviral vectorsnon-viral vectorsgene therapy vectorsnucleic acid delivery vectorscells transformed by viral vectorsnon-viral vectorsgene therapy vectors or nucleic acid delivery vectors for medical purposesdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapygene therapycell therapygene diagnosis and gene testingreagents for medical use; pharmaceutical preparationsvaccinesprophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapygene therapy and cell therapy for the diagnosistreatment or prevention of Central Nervous System diseasesLiver diseasesNeuromuscular diseases and Cardiovascular diseases
Class 42
Researchproduct development and consultancy in the field of biotechnologybiologic pharmaceutical preparationsmedical sciencechemistry and biochemistry; Research and product development in the field of pharmaceutics
Class 44
Gene and nucleic acid deliverygene and nucleic acid transfergene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disordersocular disordersdiseases of the nervous systemblood disordersliver disordersmuscular disordersmuscular skeletal disorderscancersinfectious diseasesinflammatory and auto-immune diseasesvascular disordersinherited disordersgenetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
Publications
History of USPTO decisions and trademark events.
42 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
06/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/01/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/14/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
04/14/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2023
PUBO
PUBLISHED FOR OPPOSITION
02/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/14/2022
GNRT
NON-FINAL ACTION E-MAILED
11/14/2022
CNRT
NON-FINAL ACTION WRITTEN
11/14/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/03/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/20/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/07/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/02/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/10/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/26/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/10/2022
GNSL
LETTER OF SUSPENSION E-MAILED
02/10/2022
CNSL
SUSPENSION LETTER WRITTEN
02/10/2022
DOCK
ASSIGNED TO EXAMINER
02/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2021
NWAP
NEW APPLICATION ENTERED
06/21/2021
Continuous trademark protection
Get notified about every new filing that threatens ABQURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.